Martingale Asset Management’s CryoPort CYRX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$1.17M Buy
74,406
+47,281
+174% +$607K 0.03% 504
2026
Q1
$225K Hold
27,125
0.01% 765
2025
Q4
$260K Buy
27,125
+5,605
+26% +$53K 0.01% 713
2025
Q3
$204K Buy
+21,520
New +$181K 0.01% 738

Other funds holding CYRX

Martingale Asset Management's CYRX Position: Q2 2026 in Review

Martingale Asset Management increased its CryoPort (CYRX) stake by 174% in Q2 2026, buying an estimated $607K and bringing the position to 74,406 shares worth $1.17M. The position accounts for 0.03% of the portfolio, ranked #504.

Martingale Asset Management first reported a position in CYRX in Q3 2025 and has held it in 4 quarters since. 184 funds tracked by Wall St. Rank hold CYRX as of Q2 2026.

  • Martingale Asset Management held 74,406 shares of CryoPort worth $1.17M as of Q2 2026.
  • Martingale Asset Management bought 47,281 CryoPort shares in Q2 2026, an estimated $607K.
  • CryoPort made up 0.03% of Martingale Asset Management's portfolio in Q2 2026, its #504 holding.
  • Martingale Asset Management first reported a position in CryoPort in Q3 2025 and has held it in 4 quarters since.
  • 184 funds tracked by Wall St. Rank held CryoPort as of Q2 2026.

Based on Martingale Asset Management's 13F filing for Q2 2026, filed 13 Aug 2026.